Atlas Trials

Retrospective Study on Registry Data to Evaluate the Impact of Ocrelizumab Used in Routine Care in Patients With RRMS

Clinical trial NCT04838015 · UNKNOWN

Trial details

NCT number
NCT04838015
Sponsor
University Hospital, Strasbourg, France
Status
UNKNOWN
Study type
OBSERVATIONAL
Multiple Sclerosis
Start date
2020-11-13
Primary completion
2021-11-13
Enrollment
250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.